Petco Health and Wellness (NASDAQ:WOOF) Raised to "Buy" at Zacks Investment Research – MarketBeat

Share Article

Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Petco Health and Wellness (NASDAQ:WOOF) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Thursday, Zacks.com reports. The firm presently has a $21.00 price target on the stock. Zacks Investment Research‘s price objective suggests a potential upside of 13.64% from the company’s current price.
According to Zacks, “Petco Health and Wellness is a fully-integrated health and wellness company for pets. They offer premium products, services and veterinary care. “
A number of other equities analysts have also recently issued reports on the stock. Citigroup reduced their price objective on shares of Petco Health and Wellness from $29.00 to $25.00 in a research note on Tuesday, January 18th. Wedbush raised shares of Petco Health and Wellness from a “neutral” rating to an “outperform” rating and set a $23.00 price target on the stock in a research report on Monday, December 6th. Needham & Company LLC initiated coverage on shares of Petco Health and Wellness in a research report on Thursday, December 16th. They set a “buy” rating and a $30.00 price target on the stock. Finally, Jefferies Financial Group cut shares of Petco Health and Wellness from a “buy” rating to a “hold” rating and set a $26.00 price target on the stock. in a research report on Monday, November 15th. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $25.87.
NASDAQ:WOOF opened at $18.48 on Thursday. Petco Health and Wellness has a 12-month low of $17.00 and a 12-month high of $28.73. The company has a quick ratio of 0.33, a current ratio of 0.96 and a debt-to-equity ratio of 0.74. The firm has a market capitalization of $4.19 billion and a PE ratio of 38.50. The firm has a 50-day moving average price of $19.06 and a 200 day moving average price of $20.96.
Petco Health and Wellness (NASDAQ:WOOF) last posted its quarterly earnings results on Wednesday, November 17th. The company reported $0.20 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.18 by $0.02. Petco Health and Wellness had a net margin of 2.30% and a return on equity of 8.27%. The firm had revenue of $1.44 billion during the quarter, compared to analyst estimates of $1.37 billion. The company’s revenue for the quarter was up 14.6% compared to the same quarter last year. On average, research analysts expect that Petco Health and Wellness will post 0.75 EPS for the current year.
In other news, CFO Brian Larose acquired 5,125 shares of the stock in a transaction dated Monday, December 6th. The shares were bought at an average cost of $19.45 per share, for a total transaction of $99,681.25. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.02% of the stock is owned by insiders.
Several institutional investors have recently added to or reduced their stakes in WOOF. BlackRock Inc. increased its stake in shares of Petco Health and Wellness by 11.5% during the 2nd quarter. BlackRock Inc. now owns 3,047,544 shares of the company’s stock worth $68,296,000 after purchasing an additional 313,463 shares during the last quarter. Deutsche Bank AG boosted its holdings in shares of Petco Health and Wellness by 132.6% during the 2nd quarter. Deutsche Bank AG now owns 5,984 shares of the company’s stock worth $134,000 after buying an additional 3,411 shares during the period. Bank of New York Mellon Corp boosted its holdings in shares of Petco Health and Wellness by 87.9% during the 2nd quarter. Bank of New York Mellon Corp now owns 230,117 shares of the company’s stock worth $5,158,000 after buying an additional 107,679 shares during the period. Baird Financial Group Inc. bought a new stake in shares of Petco Health and Wellness during the 2nd quarter worth about $884,000. Finally, Shell Asset Management Co. bought a new stake in shares of Petco Health and Wellness during the 2nd quarter worth about $53,000. Institutional investors own 61.38% of the company’s stock.
Petco Health and Wellness Company Profile
Petco Health and Wellness Company, Inc operates as a retailer of premium pet consumables, supplies, and companion animals and services. The company also offers grooming, in-store and online training, tele-veterinarian, and pet health insurance services, as well as veterinary services through Vetco clinics.
Featured Article: What is operating income?
Get a free copy of the Zacks research report on Petco Health and Wellness (WOOF)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Analyst Recommendations for Petco Health and Wellness (NASDAQ:WOOF)
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Before you consider Petco Health and Wellness, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Petco Health and Wellness wasn’t on the list.
While Petco Health and Wellness currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The 5 Stocks Here
 
Complete the form below to receive the latest headlines and analysts’ recommendations for your stocks with our free daily email newsletter:
Each market day you’ll get a one-minute market summary to help you invest wisely.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.
Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.
Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.
As Featured By:
MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.
Twitter Facebook StockTwits Financial Juice
MarketBeat is accredited by the Better Business Bureau
© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.

source

You might also like

Surviving 2nd wave of corona
COVID-19

Surviving The 2nd Wave of Corona

‘This too shall pass away’ this famous Persian adage seems to be defeating us again and again in the case of COVID-19. Despite every effort

@voguewellness